Spesolimab for generalized pustular psoriasis: a review of two key clinical trials supporting initial US regulatory approval

Journal article

Peer reviewed

Eran C. Gwillim and Anna J. Nichols

Frontiers in immunology, Vol.15, p.1359481

2024-07-22

PMID: 39104539

Abstract

clinical trial

efficacy

generalized pustular psoriasis

safety

spesolimab

url

https://doi.org/10.3389/fimmu.2024.1359481View

Published (Version of record) Open

1 Record Views

Title: Spesolimab for generalized pustular psoriasis: a review of two key clinical trials supporting initial US regulatory approval
Creators: Eran C. Gwillim - Jackson Health System
Anna J. Nichols - University of Miami
Publication Details: Frontiers in immunology, Vol.15, p.1359481
Grant note: Elevate Scientific Solutions LLC Boehringer Ingelheim Pharmaceuticals, Inc. Debra Brocksmith Boehringer Ingelheim (http://data.elsevier.com/vocabulary/SciValFunders/100001003)
Academic Unit: Miller School of Medicine; UMMG Dept of Dermatology & Cutaneous Surgery
Language: English
Resource Type: Journal article
PMID: 39104539
Record Identifier: 991032860883602976